Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 70 markets around the world.
 

DRUG REACTION REPORT

report

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products in over 30 European countries.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

GROWTH’S IN OUR NATURE

Since beginning our commercial activities in Europe in 2008, Accord has demonstrated dramatic growth and evolution of our product range.

Such growth is particularly illustrated by the triple digit CAGR in packs dispatched and the rapid set up in almost all European markets. Today, Accord is recognised as one of the leading companies commercializing generic drugs in Europe.

03

European Focus

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
 

04

News

05-10-2016

Intas recent acquisition

Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland

20-01-2016

Aripiprazole Accord Launch

Accord Healthcare is delighted to announce the launch of Aripiprazole Accord, generic version of Abilify®. The product is available in 5, 10, 15 and 30 mg presentations in packs of 28 tablets.

Aripiprazole Accord is administered orally and has three key indications:...